Sanctuary Advisors LLC Has $207,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Sanctuary Advisors LLC increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 6.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,065 shares of the medical instruments supplier’s stock after purchasing an additional 117 shares during the quarter. Sanctuary Advisors LLC’s holdings in LeMaitre Vascular were worth $207,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. KBC Group NV grew its position in shares of LeMaitre Vascular by 58.4% during the 4th quarter. KBC Group NV now owns 1,112 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 410 shares during the period. Empowered Funds LLC bought a new position in LeMaitre Vascular in the fourth quarter valued at approximately $150,000. SG Americas Securities LLC acquired a new stake in LeMaitre Vascular during the 4th quarter worth $158,000. Advisors Asset Management Inc. raised its position in shares of LeMaitre Vascular by 180.2% during the 3rd quarter. Advisors Asset Management Inc. now owns 1,852 shares of the medical instruments supplier’s stock valued at $172,000 after acquiring an additional 1,191 shares during the last quarter. Finally, GDS Wealth Management acquired a new position in shares of LeMaitre Vascular in the 3rd quarter valued at $205,000. 84.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

LMAT has been the subject of a number of analyst reports. Oppenheimer cut LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Lake Street Capital boosted their target price on LeMaitre Vascular from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. StockNews.com cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Wells Fargo & Company assumed coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They set an “equal weight” rating and a $95.00 price objective on the stock. Finally, Barrington Research downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Five research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.25.

LeMaitre Vascular Stock Performance

Shares of LMAT opened at $87.00 on Thursday. The firm’s 50 day moving average price is $96.75 and its two-hundred day moving average price is $94.94. LeMaitre Vascular, Inc. has a twelve month low of $62.39 and a twelve month high of $109.58. The firm has a market cap of $1.96 billion, a P/E ratio of 47.54, a PEG ratio of 2.22 and a beta of 0.96.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. The business had revenue of $55.81 million for the quarter, compared to analysts’ expectations of $55.99 million. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. On average, sell-side analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 27th. Investors of record on Thursday, March 13th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, March 13th. This is an increase from LeMaitre Vascular’s previous quarterly dividend of $0.16. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.92%. LeMaitre Vascular’s dividend payout ratio (DPR) is presently 41.24%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.